Zobrazeno 1 - 10
of 478
pro vyhledávání: '"Terris MK"'
Publikováno v:
International Journal of Nephrology and Renovascular Disease, Vol 2016, Iss Issue 1, Pp 45-52 (2016)
Reena Kabaria, Zachary Klaassen, Martha K Terris Department of Surgery, Section of Urology, Augusta University, Augusta, GA, USA Abstract: This review provides an overview of the incidence of renal cell carcinoma (RCC) and a summary of the most commo
Externí odkaz:
https://doaj.org/article/cb0380116bdd4f5bae18d512aae9fcbd
Autor:
Vidal, AC, Howard, LE, Sun, SX, Cooperberg, MR, Kane, CJ, Aronson, WJ, Terris, MK, Amling, CL, Freedland, SJ
Publikováno v:
Prostate cancer and prostatic diseases, vol 20, iss 1
BackgroundAt the population level, obesity is associated with prostate cancer (PC) mortality. However, few studies analyzed the associations between obesity and long-term PC-specific outcomes after initial treatment.MethodsWe conducted a retrospectiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::80fcd34b35043b5cc87da6a955098441
https://escholarship.org/uc/item/6dh5b9tz
https://escholarship.org/uc/item/6dh5b9tz
Autor:
Howard, LE, De Hoedt, AM, Aronson, WJ, Kane, CJ, Amling, CL, Cooperberg, MR, Terris, MK, Divers, CH, Valderrama, A, Freedland, SJ
Publikováno v:
Howard, LE; De Hoedt, AM; Aronson, WJ; Kane, CJ; Amling, CL; Cooperberg, MR; et al.(2016). Do skeletal-related events predict overall survival in men with metastatic castration-resistant prostate cancer?. PROSTATE CANCER AND PROSTATIC DISEASES, 19(4), 380-384. doi: 10.1038/pcan.2016.26. UC San Francisco: Retrieved from: http://www.escholarship.org/uc/item/4sn6w4x7
Prostate cancer and prostatic diseases, vol 19, iss 4
Prostate cancer and prostatic diseases, vol 19, iss 4
BackgroundSkeletal-related events (SREs) including pathologic fracture, spinal cord compression, radiation to bone and surgery to bone, are common in men with bone metastatic castration-resistant prostate cancer (mCRPC). Men with mCRPC are at high ri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::5417b636b0cc64f0b8bb26121b5b0fb4
http://www.escholarship.org/uc/item/4sn6w4x7
http://www.escholarship.org/uc/item/4sn6w4x7
Autor:
Terris MK (AUTHOR), Ruff PA (AUTHOR), Marotte JB (AUTHOR), Ruff, Peter A1 (AUTHOR), Marotte, Jeffrey B (AUTHOR), Terris, Martha K (AUTHOR)
Publikováno v:
Military Medicine. Feb2005, Vol. 170 Issue 2, p154-157. 4p.
Autor:
Mcginley, KF, Sun, X, Howard, LE, Aronson, WJ, Terris, MK, Kane, CJ, Amling, CL, Cooperberg, MR, Freedland, SJ
Publikováno v:
International journal of urology : official journal of the Japanese Urological Association, vol 23, iss 3
Mcginley, KF; Sun, X; Howard, LE; Aronson, WJ; Terris, MK; Kane, CJ; et al.(2015). Utilization and impact of surgical technique on the performance of pelvic lymph node dissection at radical prostatectomy: Results from the Shared Equal Access Regional Cancer Hospital database. International Journal of Urology. doi: 10.1111/iju.13027. UCSF: Retrieved from: http://www.escholarship.org/uc/item/25p3t7sk
Mcginley, KF; Sun, X; Howard, LE; Aronson, WJ; Terris, MK; Kane, CJ; et al.(2015). Utilization and impact of surgical technique on the performance of pelvic lymph node dissection at radical prostatectomy: Results from the Shared Equal Access Regional Cancer Hospital database. International Journal of Urology. doi: 10.1111/iju.13027. UCSF: Retrieved from: http://www.escholarship.org/uc/item/25p3t7sk
© 2015 The Japanese Urological Association. Objective: To evaluate performance of pelvic lymph node dissection during radical prostatectomy within an equal access care setting over a period of time, and stratified by prostate cancer risk group and s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::57e970152c7cf823c479fb41d14642dd
https://escholarship.org/uc/item/25p3t7sk
https://escholarship.org/uc/item/25p3t7sk
Autor:
Hanyok, BT, Howard, LE, Amling, CL, Aronson, WJ, Cooperberg, MR, Kane, CJ, Terris, MK, Posadas, EM, Freedland, SJ
Publikováno v:
Cancer, vol 122, iss 2
Hanyok, BT; Howard, LE; Amling, CL; Aronson, WJ; Cooperberg, MR; Kane, CJ; et al.(2015). Is computed tomography a necessary part of a metastatic evaluation for castration-resistant prostate cancer? Results from the Shared Equal Access Regional Cancer Hospital Database. Cancer. doi: 10.1002/cncr.29748. UCSF: Retrieved from: http://www.escholarship.org/uc/item/583926gg
Hanyok, BT; Howard, LE; Amling, CL; Aronson, WJ; Cooperberg, MR; Kane, CJ; et al.(2016). Is computed tomography a necessary part of a metastatic evaluation for castration-resistant prostate cancer? Results from the Shared Equal Access Regional Cancer Hospital Database. Cancer, 122(2), 222-229. doi: 10.1002/cncr.29748. UC San Diego: Retrieved from: http://www.escholarship.org/uc/item/1928v8r2
Hanyok, BT; Howard, LE; Amling, CL; Aronson, WJ; Cooperberg, MR; Kane, CJ; et al.(2015). Is computed tomography a necessary part of a metastatic evaluation for castration-resistant prostate cancer? Results from the Shared Equal Access Regional Cancer Hospital Database. Cancer. doi: 10.1002/cncr.29748. UCSF: Retrieved from: http://www.escholarship.org/uc/item/583926gg
Hanyok, BT; Howard, LE; Amling, CL; Aronson, WJ; Cooperberg, MR; Kane, CJ; et al.(2016). Is computed tomography a necessary part of a metastatic evaluation for castration-resistant prostate cancer? Results from the Shared Equal Access Regional Cancer Hospital Database. Cancer, 122(2), 222-229. doi: 10.1002/cncr.29748. UC San Diego: Retrieved from: http://www.escholarship.org/uc/item/1928v8r2
BackgroundMetastatic lesions in prostate cancer beyond the bone have prognostic importance and affect clinical therapeutic decisions. Few data exist regarding the prevalence of soft-tissue metastases at the initial diagnosis of metastatic castration-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::5f2be0a0fdccad33a009062bf11f3475
https://escholarship.org/uc/item/1928v8r2
https://escholarship.org/uc/item/1928v8r2
Autor:
Vidal, AC, Howard, LE, Cooperberg, MR, Kane, CJ, Aronson, WJ, Terris, MK, Amling, CL, Freedland, SJ
Publikováno v:
Vidal, AC; Howard, LE; Cooperberg, MR; Kane, CJ; Aronson, WJ; Terris, MK; et al.(2015). Obesity predicts prostate cancer-specific mortality after radical prostatectomy: Results from the SEARCH database. CANCER RESEARCH, 75. doi: 10.1158/1538-7445.AM2015-880. UC San Francisco: Retrieved from: http://www.escholarship.org/uc/item/08z6t1g9
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::11d2d7a2caa4d24600fff156f6b56b8e
https://escholarship.org/uc/item/08z6t1g9
https://escholarship.org/uc/item/08z6t1g9
Autor:
Zapata, DF, Howard, LE, Aronson, WJ, Kane, CJ, Terris, MK, Amling, CL, Cooperberg, MR, Freedland, SJ
Publikováno v:
International journal of urology : official journal of the Japanese Urological Association, vol 22, iss 7
International Journal of Urology, vol 22, iss 7
Zapata, DF; Howard, LE; Aronson, WJ; Kane, CJ; Terris, MK; Amling, CL; et al.(2015). Smoking is a predictor of adverse pathological features at radical prostatectomy: Results from the Shared Equal Access Regional Cancer Hospital database. International Journal of Urology, 22(7), 658-662. doi: 10.1111/iju.12773. UCSF: Retrieved from: http://www.escholarship.org/uc/item/4cg5x08z
International Journal of Urology, vol 22, iss 7
Zapata, DF; Howard, LE; Aronson, WJ; Kane, CJ; Terris, MK; Amling, CL; et al.(2015). Smoking is a predictor of adverse pathological features at radical prostatectomy: Results from the Shared Equal Access Regional Cancer Hospital database. International Journal of Urology, 22(7), 658-662. doi: 10.1111/iju.12773. UCSF: Retrieved from: http://www.escholarship.org/uc/item/4cg5x08z
© 2015 The Japanese Urological Association. Objective: To test the relationship of smoking and aggressive prostate cancer in men undergoing radical prostatectomy. Methods: A retrospective analysis of 2290 men who underwent radical prostatectomy from
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::616e0c02bc5b32bbfc853c9e7d382620
https://escholarship.org/uc/item/3qs507jr
https://escholarship.org/uc/item/3qs507jr
Autor:
Klaassen, Z, Singh, AA, Howard, LE, Feng, Z, Trock, BJ, Terris, MK, Aronson, WJ, Cooperberg, MR, Amling, CL, Kane, CJ, Partin, AWW, Han, M, Freedland, SJ
Publikováno v:
Cancer, vol 121, iss 9
Klaassen, Z; Singh, AA; Howard, LE; Feng, Z; Trock, B; Terris, MK; et al.(2015). Is clinical stage T2c prostate cancer an intermediate-or high-risk disease?. Cancer, 121(9), 1414-1421. doi: 10.1002/cncr.29147. UCSF: Retrieved from: http://www.escholarship.org/uc/item/4qp9q97h
Klaassen, Z; Singh, AA; Howard, LE; Feng, Z; Trock, BJ; Terris, MK; et al.(2015). Is clinical stage T2c prostate cancer an intermediate-or high-risk disease?. Cancer. doi: 10.1002/cncr.29147. UCSF: Retrieved from: http://www.escholarship.org/uc/item/59b1m7tq
Klaassen, Z; Singh, AA; Howard, LE; Feng, Z; Trock, B; Terris, MK; et al.(2015). Is clinical stage T2c prostate cancer an intermediate-or high-risk disease?. Cancer, 121(9), 1414-1421. doi: 10.1002/cncr.29147. UCSF: Retrieved from: http://www.escholarship.org/uc/item/4qp9q97h
Klaassen, Z; Singh, AA; Howard, LE; Feng, Z; Trock, BJ; Terris, MK; et al.(2015). Is clinical stage T2c prostate cancer an intermediate-or high-risk disease?. Cancer. doi: 10.1002/cncr.29147. UCSF: Retrieved from: http://www.escholarship.org/uc/item/59b1m7tq
© 2014 American Cancer Society. BACKGROUND: Clinical stage T2c (cT2c) is an indeterminate factor in prostate cancer (PC) risk stratification. According to the D'Amico grouping and American Urological Association guidelines, cT2c is a high risk, wher
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::ce2ef877688aaabec2782cf75cc2a682
https://escholarship.org/uc/item/59b1m7tq
https://escholarship.org/uc/item/59b1m7tq
Autor:
Mithal, P, Howard, LE, Aronson, WJ, Kane, CJ, Cooperberg, MR, Terris, MK, Amling, CL, Freedland, SJ
Publikováno v:
International journal of urology : official journal of the Japanese Urological Association, vol 22, iss 4
International Journal of Urology, vol 22, iss 4
Mithal, P; Howard, LE; Aronson, WJ; Kane, CJ; Cooperberg, MR; Terris, MK; et al.(2015). Prostate-specific antigen level, stage or Gleason score: Which is best for predicting outcomes after radical prostatectomy, and does it vary by the outcome being measured? Results from Shared Equal Access Regional Cancer Hospital database. International Journal of Urology, 22(4), 362-366. doi: 10.1111/iju.12704. UC San Francisco: Retrieved from: http://www.escholarship.org/uc/item/6083w06f
Mithal, P; Howard, LE; Aronson, WJ; Kane, CJ; Cooperberg, MR; Terris, MK; et al.(2015). Prostate-specific antigen level, stage or Gleason score: Which is best for predicting outcomes after radical prostatectomy, and does it vary by the outcome being measured? Results from Shared Equal Access Regional Cancer Hospital database. International Journal of Urology. doi: 10.1111/iju.12704. UCSF: Retrieved from: http://www.escholarship.org/uc/item/6wj4x5kk
International Journal of Urology, vol 22, iss 4
Mithal, P; Howard, LE; Aronson, WJ; Kane, CJ; Cooperberg, MR; Terris, MK; et al.(2015). Prostate-specific antigen level, stage or Gleason score: Which is best for predicting outcomes after radical prostatectomy, and does it vary by the outcome being measured? Results from Shared Equal Access Regional Cancer Hospital database. International Journal of Urology, 22(4), 362-366. doi: 10.1111/iju.12704. UC San Francisco: Retrieved from: http://www.escholarship.org/uc/item/6083w06f
Mithal, P; Howard, LE; Aronson, WJ; Kane, CJ; Cooperberg, MR; Terris, MK; et al.(2015). Prostate-specific antigen level, stage or Gleason score: Which is best for predicting outcomes after radical prostatectomy, and does it vary by the outcome being measured? Results from Shared Equal Access Regional Cancer Hospital database. International Journal of Urology. doi: 10.1111/iju.12704. UCSF: Retrieved from: http://www.escholarship.org/uc/item/6wj4x5kk
© 2015 The Japanese Urological Association. Objectives: To assess the ability of preoperative prostate-specific antigen level, Gleason score and stage to predict prostate cancer outcomes beyond biochemical recurrence, specifically castration-resista
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::1654407d6e18fc5bbbaf05aa881e8be9
https://escholarship.org/uc/item/6wj4x5kk
https://escholarship.org/uc/item/6wj4x5kk